KMDA 6-K SEC Filing Analysis

Latest settled — T+20d

KMDA ▼ -2.34% at T+20d

NEUTRAL call ✗ call lost -2.34% · α vs SPY -11.76% · entry $8.34 → $8.15

Next anchor: T+60d in 13d

Currently $7.44 · -10.79% from $8.34 entry

Entry anchored
Mar 30, 03:55 PM ET
via Databento tick

T+1d

+1.56%

call +1.56% · α +0.81%

$8.47

settled 2mo ago

T+5d

+1.56%

call +1.56% · α -2.39%

$8.47

settled 2mo ago

T+20d

-2.34%

call -2.34% · α -11.76%

$8.15

settled 6w ago

T+60d

—

call — · α —

—

in 13d

Price Chart

Loading chart...

Executive Summary

Kamada Ltd. announced a tax ruling from the Israel Tax Authority that allows eligible Nasdaq-listed shareholders to benefit from reduced Israeli withholding tax rates on its previously announced $0.25 per share cash dividend. The dividend, totaling approximately $14.4 million, is expected to be paid on April 7, 2026, to shareholders of record as of March 23, 2026.

Actionable Insight

International investors in KMDA should review their eligibility for reduced withholding taxes and submit required documentation by May 9, 2026 to maximize after-tax dividend income. This administrative update does not signal any change in dividend policy or financial performance.

Key Facts

Company obtained a tax ruling from the Israel Tax Authority regarding dividend withholding procedures.
Cash dividend of $0.25 per share ($14.4 million total) was previously announced on March 11, 2026.
Dividend payment date is April 7, 2026, with record date of March 23, 2026.
Nasdaq shareholders who are residents of countries with tax treaties with Israel may qualify for reduced withholding tax rates.
Shareholders must submit required documentation to the tax agent by May 9, 2026 to benefit from reduced rates.

Financial Impact

$14.4 million total dividend payout; potential tax savings for eligible international shareholders

dividendtax efficiency

Risk Factors

Shareholders who fail to meet documentation deadlines by May 9, 2026 will not receive tax refunds.
The ruling only affects withholding procedures, not ultimate tax liability, which depends on individual circumstances.

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

Document	Accession Number
6-K Filing (Primary)	0001213900-26-036822
Document: ea0283955-6k_kamada.htm	0001213900-26-036822
Document: 0001213900-26-036822-index-headers.html	0001213900-26-036822
Document: 0001213900-26-036822-index.html	0001213900-26-036822
Document: 0001213900-26-036822.txt	0001213900-26-036822

7 reports for KMDA

T+1T+5T+20T+60

80% Hit rate 4 of 5 directional calls best @ T+5▲ +3.31%May 13, 2026

Filters

Reports for KMDA — sortable, filterable
	Type				Now
Jun 1, 2026 12d ago	6-K BULLISH ★ 5/10	$7.70 $7.17	▼ −6.88%	▼ −4.13%	$7.44 (−3.38%)
May 13, 2026 4w ago	Press Release BEARISH ★ 7/10	$7.86 $7.60	▲ +3.31%	▲ +2.15%	$7.44 (+5.34%)
Mar 31, 2026 10w ago	6-K NEUTRAL ★ 3/10	$8.34 $8.47	▲ +1.56%	▼ −2.39%	$7.44 (−10.79%)
Mar 26, 2026 11w ago	6-K BULLISH ★ 7/10	$8.22 $8.47	▲ +3.04%	▲ +1.41%	$7.44 (−9.49%)
Mar 26, 2026 11w ago	Press Release BULLISH ★ 7/10	$8.22 $8.47	▲ +3.04%	▲ +1.41%	$7.44 (−9.49%)
Mar 11, 2026 13w ago	Press Release BULLISH ★ 8/10	$8.30 $8.34	▲ +0.47%	▲ +2.66%	$7.44 (−10.35%)
Mar 11, 2026 13w ago	Press Release NEUTRAL ★ 4/10	$8.30 $8.34	▲ +0.47%	▲ +2.66%	$7.44 (−10.35%)

US Market Status

Market Closed — Opens Mon (49h 43m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access